MARKET VECTORS ETF TR - BIOTECH ETF (BBH)

CUSIP: 57060U183

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / BIOTECH ETF
Total 13F shares
1,407,781
Share change
+157,672
Total reported value
$148,951,394
Put/Call ratio
42%
Price per share
$105.84
Number of holders
58
Value change
+$17,219,017
Number of buys
29
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 57060U183?
CUSIP 57060U183 identifies BBH - MARKET VECTORS ETF TR - BIOTECH ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - BIOTECH ETF (BBH) as of Q3 2014

As of 30 Sep 2014, MARKET VECTORS ETF TR - BIOTECH ETF (BBH) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,407,781 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, CREDIT SUISSE AG/, UBS AG, MORGAN STANLEY, CITIGROUP INC, MURPHY CAPITAL MANAGEMENT INC, Eagle Capital Management, LLC, LPL Financial LLC, HOKANSON ASSOCIATES, INC., and ALBION FINANCIAL GROUP /UT. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.